Method for synthesising 5-chloro-1-aryl-4-(4, 5-dicyano-1H-imidazol-2-yl)-3-alkyl-1Hpyrazole derivatives

Details for Australian Patent Application No. 2004230326 (hide)

Owner Evultis

Inventors Sanso', Giovanni; Mazzola, Alessandro

Agent Houlihan2

Pub. Number AU-B-2004230326

PCT Pub. Number WO2004/092159

Priority 03 04806 17.04.03 FR

Filing date 9 April 2004

Wipo publication date 28 October 2004

Acceptance publication date 12 November 2009

International Classifications

C07D 403/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

3 November 2005 PCT application entered the National Phase

  PCT publication WO2004/092159 Priority application(s): WO2004/092159

12 November 2009 Application Accepted

  Published as AU-B-2004230326

4 March 2010 Opposition Lodged

  Merial Ltd has lodged an opposition against Evultis.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004230328-Tumor antigens BFA5 for prevention and/or treatment of cancer

2004230316-Alpha substituted carboxylic acid as PPAR modulators